Q: How are these changing preferences affecting what consumers are willing to pay at the grocery store, and what does that mean for food pricing more broadly
as Januvia) Vildagliptin [7] (EU approved in 2007, and marketed in the EU by Novartis as Galvus) Saxagliptin (FDA approved in 2009, and marketed as Onglyza) Linagliptin (FDA approved in 2011, and marketed as Tradjenta by Eli Lilly and Company and Boehringer Ingelheim) [8] Gemigliptin (approved in Korea in 2012, and marketed by LG Life Sciences as Zemiglo, among other names) [9] Anagliptin (approved in Japan as Suiny in 2012
For those without underlying androgenic alopecia, hair loss from telogen effluvium may get better once the triggers (like rapid weight loss and dietary changes) are removed, and for those experiencing alopecia areata, hair regrowth may be initiated with the removal of triggers and intervention with autoimmune therapies
Q9
[1] Semaglutide may also be passed to breastfeeding infants through milk, which can cause a risk of harm
